by Brandon Drey, Daily Wire:

Myocarditis cases hit levels two-to-three times higher in people with a second dose of the Moderna COVID-19 vaccine than the Pfizer BioNTech COVID-19 vaccine, research shows.

American College of Cardiology released a study last week that showed that males and females between 18 and 39 with the Moderna vaccine had higher rates of pericarditis and myocarditis. However, males ages 18-29 had the highest rates after receiving the second dose of Moderna.